Skip to main content
. Author manuscript; available in PMC: 2023 Jun 21.
Published in final edited form as: Vaccine. 2022 Nov 17;41(Suppl 1):A142–A152. doi: 10.1016/j.vaccine.2022.10.060

Table 3.

Estimated probability of type 2 transmission die-out number of iterations with no ongoing transmission as of December 31, 2026) and the expected number of affected modeled subpopulations out of 720 in 100 stochastic iterations for the scenarios modeled (see main text for descriptions).

Scenario Probability of die out Estimated expected affected modeled subpopulations out of 720 (median) [range]
RC (A0) 1% 40 (23) [5 – 158]
B0 0% 17 (11) [5 – 82]
C0 1% 36 (21) [5 – 198]
D0 0% 27 (19) [6 – 136]
E0 0% 53 (49) [6 – 197]
F0 0% 63 (49) [5 – 261]
A1 0% 69 (49) [15 – 279]
A2 2% 13 (7) [5 – 63]
A3 1% 33 (18) [5 – 187]
A4 0% 46 (28) [5 – 183]
A5 13% 42 (28) [5 – 174]
A6 15% 44 (32) [5 – 160]
A7 25% 34 (19) [4 – 155]
A8 20% 37 (26) [5 – 132]
A9 1% 27 (18) [5 – 116]
A2379 81% 6 (4) [3 – 49]
B2379 95% 4 (4) [3 –15]
A23579 85% 6 (4) [3 –48]
B23579 96% 4 (3) [3 –14]
G2379 95% 4 (4) [3 –15]
H2379 88% 5 (4) [3 –41]
I2379 97% 4 (4) [3 –13]
J2379 93% 4 (4) [3 –19]
B2 1% 9 (7) [5 –41]
G2 0% 9 (7) [5 –47]
G239 0% 7 (6) [5 –17]
G2369 58% 5 (5)[5 –16]

Abbreviations: RC, reference case, for details about scenarios see Table 1.